Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Novel combined immunotherapy promising for treatment of malignant brain tumors

Novel combined immunotherapy promising for treatment of malignant brain tumors

Researchers present positive results of Phase II clinical trial of eliglustat tartrate

Researchers present positive results of Phase II clinical trial of eliglustat tartrate

FDA issues advisory on prostate cancer drugs

FDA issues advisory on prostate cancer drugs

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

Ago2 protein helps generate microRNAs: CSHL researchers

Ago2 protein helps generate microRNAs: CSHL researchers

Takeda settles with six defendants in generic ACTOS, ACTOplus met patent infringement lawsuit

Takeda settles with six defendants in generic ACTOS, ACTOplus met patent infringement lawsuit

Study: Lower blood oxygen levels can lead to heart abnormalities in children with sickle cell disease

Study: Lower blood oxygen levels can lead to heart abnormalities in children with sickle cell disease

Researchers receive $5.7M in funding to investigate new ways to treat uterine fibroids

Researchers receive $5.7M in funding to investigate new ways to treat uterine fibroids

AMAG Pharmaceuticals reports Feraheme net product revenues of $13.1M for first-quarter 2010

AMAG Pharmaceuticals reports Feraheme net product revenues of $13.1M for first-quarter 2010

Protalix BioTherapeutics submits validation data for taliglucerase alfa manufacturing process to the FDA

Protalix BioTherapeutics submits validation data for taliglucerase alfa manufacturing process to the FDA

Black children with chronic kidney disease have severe anemia than white children: Study

Black children with chronic kidney disease have severe anemia than white children: Study

High incidence of MDS among seniors, elderly at increased risk of premature death: Study

High incidence of MDS among seniors, elderly at increased risk of premature death: Study

Study reveals new marker for predicting patients requiring blood transfusion in ICU

Study reveals new marker for predicting patients requiring blood transfusion in ICU

Affymax institutes quiet period in connection with Hematide Phase 3 result analysis

Affymax institutes quiet period in connection with Hematide Phase 3 result analysis

Human lymphocytes produce hepcidin that regulate iron levels in the body: Study

Human lymphocytes produce hepcidin that regulate iron levels in the body: Study

FDA approves Novartis Pharmaceuticals' Zortress for preventing rejection of kidney transplants

FDA approves Novartis Pharmaceuticals' Zortress for preventing rejection of kidney transplants

Roche's progress of RG7348 into Phase I clinical trial triggers $6.5M milestone payment to Ligand

Roche's progress of RG7348 into Phase I clinical trial triggers $6.5M milestone payment to Ligand

New research indicates patients may develop anemia after gastric bypass surgery

New research indicates patients may develop anemia after gastric bypass surgery

ABRAXANE-bevacizumab combination therapy may exhibit potential in treatment of triple-negative breast cancers

ABRAXANE-bevacizumab combination therapy may exhibit potential in treatment of triple-negative breast cancers

Alexion Pharmaceuticals completes enrollment in Soliris clinical studies for aHUS

Alexion Pharmaceuticals completes enrollment in Soliris clinical studies for aHUS

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.